Agentic AI and Infrastructure Dominate Venture Capital Funding in Massive Weekly Round
Venture capital activity remains heavily concentrated on artificial intelligence and supporting infrastructure, with recent financing announcements highlighting massive capital inflows into early and late-stage enterprises alike. A review of major capital raises reveals that emerging technologies continue to command enormous valuations, led by substantial deals in agentic systems, specialized compute architecture, and applied industrial automation.
The Largest Rounds Highlight AI Dominance
The weekly funding landscape was anchored by monumental investments in artificial intelligence developers. Leading the activity was Mirendil, a startup building agentic artificial intelligence for research and development, which secured a staggering $1 billion Series A round backed by Kleiner Perkins and Clearlake Capital. Hot on its heels was Mercor, a platform connecting developers with human specialists for model training, pulling in $750 million in a Series D financing that valued the young enterprise at $20 billion.
Infrastructure plays also captured significant institutional capital. Torus, a Salt Lake City manufacturer of distributed power and compute systems, gathered $500 million in growth financing led by Magnetar Capital. The company concurrently introduced Foundry, a modular offering aimed at inference compute infrastructure. Meanwhile, Mavria emerged from stealth with $130 million in combined pre-seed and seed capital, reaching a $1 billion valuation with backing from Paradigm for its approach to standardizing infrastructure deployment.
Industrial Automation and Enterprise Software
Physical robotics and enterprise tooling also saw considerable traction among venture capitalists looking beyond pure software plays. Notable transactions from the period include:
- Path Robotics closed a $300 million Series E financing led by Georgian, valuing the manufacturing automation developer at $2.45 billion.
- LangChain secured $300 million in Series C funding at a $3 billion valuation, led by CapitalG, to support its agent governance platform.
- Nominal pulled in $240 million for its hardware engineering intelligence tools, hitting a $3 billion valuation in a round co-led by Lightspeed Venture Partners and Insight Partners.
- Rox announced a $100 million Series B funding led by General Catalyst and March Capital to scale its enterprise sales revenue agents.
Diversification Across Fintech and Biotech
While artificial intelligence claimed the lion share of attention, several notable financings occurred in consumer fintech, financial data, and life sciences. Imprint, a payments and customer loyalty platform, collected $130 million at a $1.9 billion valuation in a Khosla Ventures-led round. In financial data, Databento secured $100 million in Series C funding, achieving unicorn status with a $1.1 billion valuation backed by Fifth Down Capital.
In the biotechnology sector, Delix Therapeutics closed a $100 million Series C financing. Co-led by Johnson & Johnson Innovation and the Dementia Discovery Fund, the capital will support the company efforts to optimize neuroplastogenic therapeutics for psychological and psychiatric care. These diverse raises demonstrate that while deep tech and compute remain primary drivers, specialized markets continue to secure robust venture backing.